Sort
326,823 grants matching “clinical trial”
Hypoxic Adenosine Responses
$2,049,519Michael R Blackburn · University Of Texas Hlth Sci Ctr Houston · P01 · FY2016 · HL
Genetic Approaches to Cancer Immunotherapy
$2,049,200Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Comparative Oncology Program Laboratory
$2,049,125Amy Leblanc · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Head and Neck Cancer SPORE at the University of Wisconsin
$2,049,112Paul M Harari · University Of Wisconsin-Madison · P50 · FY2024 · CA
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
$2,049,085Sanjiv S Gambhir · Stanford University · U54 · FY2017 · CA
MOLECULAR BIOMARKERS FOR ENVIRONMENTAL CARCINOGENS
$2,048,976John D Groopman · Johns Hopkins University · P01 · FY2006 · ES
FLUORESCENCE SPECTROSCOPY FOR CERVICAL NEOPLASIA
$2,048,936University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA
Building Mood State Classifiers to Inform Deep Brain Stimulation (DBS) of Treatment-Resistant Bipolar Depression
$2,048,884Wayne K Goodman · Baylor College Of Medicine · UH3 · FY2024 · NS
SWOG Biospecimen Bank to Support NCI NCTN
$2,048,483Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA
Comprehensive Cancer Center of Wake Forest University CCOP Research Base
$2,048,319Edward G Shaw · Wake Forest University Health Sciences · U10 · FY2009 · CA
SPORE in Lymphoma
$2,048,062Helen E Heslop · Baylor College Of Medicine · P50 · FY2023 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$2,048,056Michael A Caligiuri · Ohio State University · P01 · FY2016 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$2,048,056Michael A Caligiuri · Ohio State University · P01 · FY2015 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,047,881Gordon R. Bernard · Vanderbilt University · UL1 · FY2010 · RR
ADULT AIDS CLINICAL TRIALS UNIT
$2,047,755Case Western Reserve University · U01 · FY2003 · AI
Statistical Methods for Integrative Genomics in Cancer
$2,047,749William James Gauderman · University Of Southern California · P01 · FY2023 · CA
Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia
$2,047,637Michael Rutledge Debaun · Washington University · R01 · FY2006 · HL
Molecular and Clinical Approaches to Colon Cancer Precursors
$2,047,627Sean Vahram Tavtigian · University Of Utah · P01 · FY2014 · CA
Investigation On The Behavioral Effects And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$2,047,482Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2025 · DA
Brain Tumor Therapeutic Efficacy by Quantitative MR
$2,047,230Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2016 · CA
TOPIC 423 (PHASE II): AN INTEGRATED MULTI-LEVEL DECISION SUPPORT PLATFORM TO ADDRESS PATIENT-CENTERED AND EVIDENCE-BASED SOCIAL DETERMINANTS OF HEALTH AMONG CANCER PATIENTS.
$2,047,174Cupid Chan · Pistevo Decision Llc · N44 · FY2023 · CA
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
$2,047,069Stephen A Spector · University Of California, San Diego · UM1 · FY2021 · AI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,046,999Roy S Herbst · Yale University · P50 · FY2022 · CA
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,046,978Stephen A Spector · University Of California, San Diego · UM1 · FY2015 · AI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK
$2,046,878Barbara Driver · Westat, Inc. · N01 · FY2024 · HD